Organized by the Task Force Health Care, in the week of 13-17 March 2017 a delegation of Colombian health care workers visited the Netherlands. All presentations related to the Anticoagulation Clinic of Gelre Ziekenhuizen and Portavita can be found here.
Anticoagulation patients in Suriname receiving better treatment thanks to Portavita’s e-Health platform.
Evert Jan Hoijtink, Founder and CEO of Portavita will be present at the International Conference on Integrated Care 23rd till the 25th of May 2016 in Barcelona.
Evert Jan Hoijtink, Founder and CEO of Portavita was present at the SMART Hospital & Healthcare in Singapore from 25th till the 29th of April
Portavita was present at Arab Health 2016.
Workshop on Personal Health Systems for Chronic Diseases (PHSCD 2015) at Pervasive Health 2015, Istanbul, Turkey, May 20, 2015
November 12, 2014 – At the end of January 2014 Portavita received the ISO certification for the ISO 13485:2003 standard. DEKRA recently conducted a first surveillance audit. The auditor concluded that Portavita again shows that it meets the high international quality standards and thereby retains the certification.
ISO 13485:2003 is an international standard related to quality management systems in the field of medical devices. ISO 13485:2003 covers the design, the development, production, implementation and services of medical devices.
Today, the first 5 patients with diabetes type 2 have been recruited to run the trials of FP7 project COMMODITY12. 15 more will follow.
Mejor tratamiento de pacientes anticoagulados en Surinam gracias a la plataforma eHealth de Portavita
Ámsterdam, 30 de agosta de 2016 - Portavita, líder de mercado en software para el apoyo de personas con enfermedades crónicas, ha implementado recientemente en Surinam su plataforma digital de seguimiento y tratamiento anticoagulantes. Gracias a ello, los pacientes con trombosis en Surinam pueden recibir un tratamiento mucho mejor, lo cual conduce a una reducción de las complicaciones y los costes de asistencia sanitaria.
Anticoagulation patients in Suriname receiving better treatment thanks to Portavita’s e-Health platform
Amsterdam, 30 August 2016 - Portavita, market leader in Integrated Care Solutions for chronic care and prevention programs, has recently launched its Integrated Anticoagulation Care solution, “Portavita Anticoagulation”, in Suriname. Patients with a high clotting risk in Suriname can now receive an improved treatment experience, leading to fewer complications at lower care costs.